US20100316830A1 - Reinforcing ring - Google Patents

Reinforcing ring Download PDF

Info

Publication number
US20100316830A1
US20100316830A1 US12/713,988 US71398810A US2010316830A1 US 20100316830 A1 US20100316830 A1 US 20100316830A1 US 71398810 A US71398810 A US 71398810A US 2010316830 A1 US2010316830 A1 US 2010316830A1
Authority
US
United States
Prior art keywords
wire
reinforcing ring
loops
ring
circular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/713,988
Inventor
David Ernest Hartley
Edward Graham Mills
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
William A Cook Australia Pty Ltd
Cook Inc
Original Assignee
William A Cook Australia Pty Ltd
Cook Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William A Cook Australia Pty Ltd, Cook Inc filed Critical William A Cook Australia Pty Ltd
Assigned to WILLIAM A. COOK AUSTRALIA PTY. LTD., AN AUSTRALIAN CORPORATION, COOK INCORPORATED, A CORPORATION OF THE STATE OF INDIANA reassignment WILLIAM A. COOK AUSTRALIA PTY. LTD., AN AUSTRALIAN CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MILLS, EDWARD GRAHAM, HARTLEY, DAVID ERNEST
Publication of US20100316830A1 publication Critical patent/US20100316830A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/89Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/061Blood vessels provided with means for allowing access to secondary lumens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/21Circular sheet or circular blank

Definitions

  • This invention relates to a medical device and more particularly to a reinforcing ring used in stent graft device.
  • Stent grafts are used to bridge a defect in the vasculature of a patient and can be deployed into the vasculature endovascularly. This requires that the device can be constrained into a small delivery device and be able to expand or be expanded when release within the vasculature.
  • a fenestration an aperture in the stent graft, known as a fenestration, to enable access from a deployed stent graft to that side branch.
  • a fenestration may be reinforced with a peripheral circular ring stitched to the graft material around the fenestration. It is also desirable in some situations to provide a side branch stent graft extending through the fenestration and into the side branch.
  • an inflatable balloon can be used to expand the branch stent graft into the fenestration and for this purpose the reinforcing ring must be able to resist expansion of its diameter.
  • the ring must be resilient so that it can be distorted into its deployment configuration but when released expand back to its circular configuration.
  • resilient when used in relation to a wire used to manufacture a reinforcing ring refers to a wire which is substantially inextensible but which has a spring function so that when distorted and released returns to its original configuration.
  • such a reinforcing rings is manufactured from a metal known as a superelastic metal such as, but not restricted, to a nickel titanium alloy known as Nitinol.
  • a superelastic metal such as, but not restricted, to a nickel titanium alloy known as Nitinol.
  • Nitinol a nickel titanium alloy
  • the desired final shape is formed from a wire on a former and then the wire on the former is heated above a temperature which sets the wire in the new shape. Upon cooling the ring holds it formed shape and can be distorted and resiliently returns to the formed shape.
  • the reinforcing rings discussed in PCT Publication WO 2005/034808 mentioned above when formed from a resilient wire each have substantially circular loops at the terminal ends of the wire. These loops prevent the sharp end of the wire puncturing the vasculature into which the stent graft is deployed.
  • electropolish rings incorporating these prior art loops it is necessary to straighten out the ring but the prior art loops do not permit efficient electropolishing because parts of the loops touch the wire of the ring.
  • the invention is said to reside in a reinforcing ring for a fenestration of a stent graft, the reinforcing ring comprising a plurality of turns of a substantially inextensible resilient wire in a circular two dimensional shape and terminal ends at each end of the wire, the terminal ends each comprising a loop and a tail folded back and extending around the circular shape whereby the reinforcing ring can be straightened out for subsequent surface treatment with substantially no part of the circular shape, the loops or tails touching each other.
  • the substantially inextensible resilient wire can be a superelastic wire such as a wire formed from a nickel titanium alloy such as Nitinol.
  • the forming of the loop provides an end which is less likely to potentially damage the vasculature or a graft material.
  • the provision of the tail which is folded back and extending around the circular shape enables the subsequent surface treatment to be carried out on all of the surfaces of the wire after it has been straightened out in a substantially linear manner.
  • terminal loops at each end of the wire can extend out of the plane of the circular shape at approximately right angles thereto.
  • each of the tails of the terminal loops comprises an enlarged end.
  • the enlarged end can be in the form of a ball of solder or the like.
  • the subsequent surface treatment such may be polishing, passivation or coating.
  • the polishing may be electropolishing, mechanical polishing or chemical polishing. According to the present invention these processes can be carried out on the entire surface of the reinforcing ring of the present invention because when it is straightened out no part of the loops or tails touch each other.
  • passivation in relation to a nickel titanium alloy is intended to provide a protective nickel-depleted titanium rich oxide layer for good biocompatibility. Passivation also improves the corrosion resistance of the surface.
  • Electropolishing also referred to as electrochemical polishing, is an electrochemical process that removes material from a metallic workpiece. It is used to polish, passivate and deburr metal parts. It is often described as the reverse of electroplating. It differs from anodizing in that the purpose of anodizing is to grow a thick, protective oxide layer on the surface of a material (usually aluminum) rather than polish.
  • Electrolytes used for electropolishing are most often concentrated acid solutions having a high viscosity such as mixtures of sulfuric acid and phosphoric acid. Other electropolishing electrolytes reported in the literature include mixtures of perchlorates with acetic anhydride and methanolic solutions of sulfuric acid.
  • anodic leveling is achieved by applying a specific electrochemical condition, most often involving a mass transport limited dissolution reaction.
  • a second condition for achieving polishing is that surface heterogeneities due to crystal orientation in a polycrystalline material are suppressed and that no pitting occurs.
  • the reinforcing ring after it has been formed and suitably heat treated, as discussed above, so that it will return to its circular ring shape can be stretched out into a linear form so that no part of the ring touches another and then can be electrochemically polished or have some other surface treatment applied. Upon being released from its straightened out condition the ring will return to its circular ring shape.
  • FIG. 1 shows a first embodiment of a reinforcing ring of the present invention
  • FIG. 2 shows an alternative embodiment of a reinforcing ring of the present invention
  • FIG. 3 shows an alternative embodiment of a reinforcing ring of the present invention
  • FIG. 4 shows a reinforcing ring according to the embodiment shown in FIG. 2 stitched into a portion of graft material
  • FIG. 5 shows a reinforcing ring according to the embodiments shown in FIGS. 1 to 3 stretched out for electropolishing
  • FIG. 6 shows a stent graft incorporating fenestrations and a reinforcing ring according to the present invention
  • FIG. 7 shows an alternative embodiment of the invention.
  • FIG. 8 shows a leg extension stent graft incorporating a ring reinforcement of the embodiment of FIG. 7 .
  • the reinforcing ring 2 is formed into a two dimensional circular shape of a superelastic wire 4 .
  • the ring has a diameter of from 5 to 15 mm when it is used as a reinforcing ring for a fenestration and from 10 to 40 mm when it is used as an end reinforcement for a tubular stent graft.
  • the ring 2 is formed from a superelastic metal wire such as a nickel titanium alloy such as Nitinol.
  • the wire can have a diameter of from 0.1 mm to 1 mm and preferably a diameter of from 0.15 mm to 0.3 mm.
  • the ring has nearly two turns of the wire 4 and each end of the wire terminates in a loop 6 and a tail 8 .
  • the loop 6 is generally of a diameter through which can be passed a needle during stitching of the reinforcing ring into a graft material. Typically the loops may have a diameter of from 1 mm to 2 mm.
  • the tail 8 extends back around the periphery of the reinforcing ring and when the wire is stretched out for passivation and/or electropolishing the tails are slightly spaced away from it (see FIG. 5 ). After electropolishing or other surface treatment and when the reinforcing ring is stitched into a stent graft there is no problem with the parts of the ring touching each other.
  • Each of the tails 8 ends in an enlarged end 9 .
  • the enlarged end 9 can be for instance in the form of a ball formed from solder, fused material of the ring of the like.
  • the enlarged end is provided to protect the fabric of a stent graft unto which the reinforcing ring is mounted from the sharp points at the ends of the wire and to assist the sewing of the end of the wire as a stitch can be added next to the ball which stitch can engage against the enlarged end or ball and prevents the wire from being pulled in one direction.
  • FIG. 2 shows an alternative embodiment of reinforcing ring according to the invention.
  • the reinforcing ring 10 is formed into a two dimensional circular shape of a superelastic wire 12 .
  • the ring 10 has two turns of the wire 12 and each end of the wire terminates in a loop 14 and a tail 16 .
  • the loops 14 overlap each other.
  • the tails 16 extend back around the periphery of the reinforcing ring and when the wire is stretched out for passivation and/or electropolishing the tails are slightly spaced away from it (see FIG. 5 ).
  • Each of the tails 16 ends in an enlarged end 17 .
  • FIG. 3 shows an alternative embodiment of reinforcing ring according to the invention.
  • the reinforcing ring 20 is formed into a two dimensional circular shape of a superelastic wire 22 .
  • the ring 20 has two complete turns and a little more of the wire 22 and each end of the wire terminates in a loop 24 and a tail 26 .
  • the tails 26 extend back towards each other.
  • the tails 26 extend back around the periphery of the reinforcing ring and when the wire is stretched out for passivation and/or electropolishing the tails are slightly spaced away from it (see FIG. 5 ).
  • Each of the tails 26 ends in an enlarged end 27 .
  • FIG. 4 shows a reinforcing ring according to the embodiment shown in FIG. 2 stitched into a portion of graft material.
  • the graft material 30 has a fenestration 32 and around the fenestration is a reinforcing ring 10 retained in place by blanket type stitching 36 .
  • the reinforcing ring 10 is of the type shown in FIG. 2 and the loops 14 overlap and two of the stitches of the stitching pass through the loops 14 .
  • These extra stitches 37 are provided into the loops 14 and through the graft material.
  • the tails 16 are also retained within the stitches 36 . It will be noted in particular that the stitch 36 a engages against the enlarged end or ball 17 .
  • FIG. 5 shows a reinforcing ring according to the embodiments shown in FIGS. 1 to 3 stretched out for passivation and/or electropolishing.
  • the wire 40 is stretched essentially by pulling upon the tails 42 at each end out so that no portion of the rings, loops or tails touch another. It will be particularly noted that when stretched out the tail 42 does not touch the wire 40 thereby ensuring good electropolishing all over the wire.
  • FIG. 6 shows a stent graft incorporating fenestrations and a reinforcing ring according to the present invention.
  • a stent graft 50 comprises a tubular wall body portion 53 .
  • the tubular wall body portion is a biocompatible graft material such as Dacron, Thoralon, expanded PTFE material or a naturally occurring biomaterial, such as an extracellular matrix, such as small intestinal submucosa or other suitable material.
  • Gianturco style zig zag Z stents 55 are provided inside the graft material at each end and on the central tubular wall body portion Gianturco style zig zag Z stents 57 are provided on the outside of the graft material. There may be further Gianturco style zig zag Z stents than those illustrated depending upon the overall length of the stent graft 50 . Other forms of stent may also be used.
  • tubular wall body portion 53 there are two substantially circular fenestrations or apertures 59 on the tubular wall of the stent graft.
  • fenestrations or apertures 59 are substantially circular.
  • Radiopaque markers 61 are provided at each end of the fenestration 59 to assist a physician to locate the fenestration 59 in respect to a side vessel extending from a main vessel.
  • the radiopaque markers 61 may be gold or other convenient material.
  • a reinforcement ring 62 of the present invention is provided around the periphery of the fenestration 59 to give good dimensional stability to the fenestration 59 .
  • the reinforcing ring is manufactured from Nitinol wire.
  • the ring 62 may be formed from stainless steel or any other convenient material.
  • Stitching 63 is provided to retain the ring 62 around the periphery of the fenestration 59 .
  • FIG. 6 there is shown a scalloped fenestration 65 which opens to the end 67 of the stent graft.
  • FIG. 7 shows an alternative embodiment of the invention.
  • the reinforcing ring 70 has nearly two full turns of Nitinol wire 72 and each end of the wire terminates in a loop 74 .
  • Each of the loops extend out of the plane of the circular shape at approximately right angles thereto.
  • the tails 76 of the loops extend around the periphery of the circular shape and each of the tails 76 ends in an enlarged end 78 .
  • the reinforcement ring of this embodiment is useful as a reinforcing ring at the end of a tubular body of graft material such as an arm or leg of a stent graft where the ring is stitched around the end of the tubular body and the loops at right angles to the plane of the ring extend along the tubular body and can be stitched thereto.
  • FIG. 8 shows a leg extension stent graft incorporating a ring reinforcement of the embodiment of FIG. 7 .
  • the leg extension 80 has a tubular body 82 of a graft material and a reinforcement ring 70 at its proximal end 84 .
  • the ring has loops 74 which extend out of the plane of the circular shape of the ring at approximately right angles and along the side of the tubular body. Stitching 86 fastens the ring to the tubular body and also some of the stitches pass through the loops 74 and over the tails 76 .

Abstract

A reinforcing ring (10) for a fenestration (32) of a stent graft which can be surface treated such as by passivation and/or electropolishing. The reinforcing ring has several turns of a substantially inextensible resilient wire (12) in a circular two dimensional planar shape and terminal ends (14) at each end of the wire. The terminal ends each comprising a loop (14) and a tail (16). The tail is folded back and extends around the circular shape. Each of the tails of the terminal loops can have an enlarged end. The reinforcing ring can be straightened out for surface treatment such as passivation and/or electropolishing with substantially no part of the circular shape, the loops or tails touching each other.

Description

    TECHNICAL FIELD
  • This invention relates to a medical device and more particularly to a reinforcing ring used in stent graft device.
  • BACKGROUND OF THE INVENTION
  • Stent grafts are used to bridge a defect in the vasculature of a patient and can be deployed into the vasculature endovascularly. This requires that the device can be constrained into a small delivery device and be able to expand or be expanded when release within the vasculature.
  • Where there are side branches to the vasculature it may be necessary to provide an aperture in the stent graft, known as a fenestration, to enable access from a deployed stent graft to that side branch. Such a fenestration may be reinforced with a peripheral circular ring stitched to the graft material around the fenestration. It is also desirable in some situations to provide a side branch stent graft extending through the fenestration and into the side branch.
  • PCT Publication WO 2005/034808 entitled “Fenestrated Stent Graft” describes the use of resilient reinforcing rings in stent grafts and the teachings therein are incorporated herein in their entirety.
  • To obtain a good seal of the branch stent graft within the fenestration an inflatable balloon can be used to expand the branch stent graft into the fenestration and for this purpose the reinforcing ring must be able to resist expansion of its diameter. At the same time the ring must be resilient so that it can be distorted into its deployment configuration but when released expand back to its circular configuration. In this specification the term resilient when used in relation to a wire used to manufacture a reinforcing ring refers to a wire which is substantially inextensible but which has a spring function so that when distorted and released returns to its original configuration.
  • This invention will be discussed in relation to the application of a reinforcing ring to a fenestration but such a ring may have greater applicability.
  • Generally such a reinforcing rings is manufactured from a metal known as a superelastic metal such as, but not restricted, to a nickel titanium alloy known as Nitinol. To form a ring of a superelastic metal the desired final shape is formed from a wire on a former and then the wire on the former is heated above a temperature which sets the wire in the new shape. Upon cooling the ring holds it formed shape and can be distorted and resiliently returns to the formed shape.
  • The reinforcing rings discussed in PCT Publication WO 2005/034808 mentioned above when formed from a resilient wire each have substantially circular loops at the terminal ends of the wire. These loops prevent the sharp end of the wire puncturing the vasculature into which the stent graft is deployed. When it is desired to electropolish rings incorporating these prior art loops it is necessary to straighten out the ring but the prior art loops do not permit efficient electropolishing because parts of the loops touch the wire of the ring.
  • SUMMARY OF THE INVENTION
  • In one form therefore the invention is said to reside in a reinforcing ring for a fenestration of a stent graft, the reinforcing ring comprising a plurality of turns of a substantially inextensible resilient wire in a circular two dimensional shape and terminal ends at each end of the wire, the terminal ends each comprising a loop and a tail folded back and extending around the circular shape whereby the reinforcing ring can be straightened out for subsequent surface treatment with substantially no part of the circular shape, the loops or tails touching each other.
  • The substantially inextensible resilient wire can be a superelastic wire such as a wire formed from a nickel titanium alloy such as Nitinol.
  • The forming of the loop provides an end which is less likely to potentially damage the vasculature or a graft material. The provision of the tail which is folded back and extending around the circular shape enables the subsequent surface treatment to be carried out on all of the surfaces of the wire after it has been straightened out in a substantially linear manner.
  • Preferably there are substantially two circular turns of the wire.
  • In preferred embodiments the terminal loops at each end of the wire can overlap or be spaced apart either past each other or nearly reaching each other.
  • In one embodiment there are two complete circular turns of the wire and the loops extend further around the circular shape.
  • In one embodiment the terminal loops at each end of the wire can extend out of the plane of the circular shape at approximately right angles thereto.
  • In one embodiment each of the tails of the terminal loops comprises an enlarged end. The enlarged end can be in the form of a ball of solder or the like.
  • The subsequent surface treatment such may be polishing, passivation or coating. The polishing may be electropolishing, mechanical polishing or chemical polishing. According to the present invention these processes can be carried out on the entire surface of the reinforcing ring of the present invention because when it is straightened out no part of the loops or tails touch each other.
  • The process of passivation in relation to a nickel titanium alloy is intended to provide a protective nickel-depleted titanium rich oxide layer for good biocompatibility. Passivation also improves the corrosion resistance of the surface.
  • Electropolishing, also referred to as electrochemical polishing, is an electrochemical process that removes material from a metallic workpiece. It is used to polish, passivate and deburr metal parts. It is often described as the reverse of electroplating. It differs from anodizing in that the purpose of anodizing is to grow a thick, protective oxide layer on the surface of a material (usually aluminum) rather than polish.
  • For electropolishing typically, a metal work piece is immersed in a temperature controlled bath of electrolyte and connected to the positive terminal of a DC power supply, the negative terminal being attached to an auxiliary electrode. A current passes from the anode where metal on the surface is oxidized and dissolved in the electrolyte. At the cathode, a reduction reaction, normally hydrogen evolution, takes place. Electrolytes used for electropolishing are most often concentrated acid solutions having a high viscosity such as mixtures of sulfuric acid and phosphoric acid. Other electropolishing electrolytes reported in the literature include mixtures of perchlorates with acetic anhydride and methanolic solutions of sulfuric acid. To achieve electropolishing of a rough metal surface, the protruding parts of a surface profile must dissolve faster than the recesses. This behavior (referred to as anodic leveling) is achieved by applying a specific electrochemical condition, most often involving a mass transport limited dissolution reaction. A second condition for achieving polishing is that surface heterogeneities due to crystal orientation in a polycrystalline material are suppressed and that no pitting occurs. These conditions, often associated with surface brightening, are usually fulfilled with the above mentioned polishing electrolytes and with proper process control. Anodic dissolution under electropolishing conditions deburrs metal objects due to increased current density on corners and burrs.
  • Hence in the present invention, the reinforcing ring after it has been formed and suitably heat treated, as discussed above, so that it will return to its circular ring shape can be stretched out into a linear form so that no part of the ring touches another and then can be electrochemically polished or have some other surface treatment applied. Upon being released from its straightened out condition the ring will return to its circular ring shape.
  • BRIEF DESCRIPTION OF THE DRAWING
  • This then generally describes the invention but to assist with understanding reference will now be made to the accompanying drawings which show preferred embodiments of the invention.
  • In the drawings:
  • FIG. 1 shows a first embodiment of a reinforcing ring of the present invention;
  • FIG. 2 shows an alternative embodiment of a reinforcing ring of the present invention;
  • FIG. 3 shows an alternative embodiment of a reinforcing ring of the present invention;
  • FIG. 4 shows a reinforcing ring according to the embodiment shown in FIG. 2 stitched into a portion of graft material;
  • FIG. 5 shows a reinforcing ring according to the embodiments shown in FIGS. 1 to 3 stretched out for electropolishing;
  • FIG. 6 shows a stent graft incorporating fenestrations and a reinforcing ring according to the present invention;
  • FIG. 7 shows an alternative embodiment of the invention; and
  • FIG. 8 shows a leg extension stent graft incorporating a ring reinforcement of the embodiment of FIG. 7.
  • DETAILED DESCRIPTION
  • Now looking more closely at the drawings and in particularly the embodiment shown in FIG. 1 it will be seen that the reinforcing ring 2 is formed into a two dimensional circular shape of a superelastic wire 4. The ring has a diameter of from 5 to 15 mm when it is used as a reinforcing ring for a fenestration and from 10 to 40 mm when it is used as an end reinforcement for a tubular stent graft. The ring 2 is formed from a superelastic metal wire such as a nickel titanium alloy such as Nitinol. The wire can have a diameter of from 0.1 mm to 1 mm and preferably a diameter of from 0.15 mm to 0.3 mm.
  • The ring has nearly two turns of the wire 4 and each end of the wire terminates in a loop 6 and a tail 8. The loop 6 is generally of a diameter through which can be passed a needle during stitching of the reinforcing ring into a graft material. Typically the loops may have a diameter of from 1 mm to 2 mm. The tail 8 extends back around the periphery of the reinforcing ring and when the wire is stretched out for passivation and/or electropolishing the tails are slightly spaced away from it (see FIG. 5). After electropolishing or other surface treatment and when the reinforcing ring is stitched into a stent graft there is no problem with the parts of the ring touching each other.
  • Each of the tails 8 ends in an enlarged end 9. The enlarged end 9 can be for instance in the form of a ball formed from solder, fused material of the ring of the like. The enlarged end is provided to protect the fabric of a stent graft unto which the reinforcing ring is mounted from the sharp points at the ends of the wire and to assist the sewing of the end of the wire as a stitch can be added next to the ball which stitch can engage against the enlarged end or ball and prevents the wire from being pulled in one direction.
  • FIG. 2 shows an alternative embodiment of reinforcing ring according to the invention. The reinforcing ring 10 is formed into a two dimensional circular shape of a superelastic wire 12. The ring 10 has two turns of the wire 12 and each end of the wire terminates in a loop 14 and a tail 16. The loops 14 overlap each other. The tails 16 extend back around the periphery of the reinforcing ring and when the wire is stretched out for passivation and/or electropolishing the tails are slightly spaced away from it (see FIG. 5). Each of the tails 16 ends in an enlarged end 17.
  • FIG. 3 shows an alternative embodiment of reinforcing ring according to the invention. The reinforcing ring 20 is formed into a two dimensional circular shape of a superelastic wire 22. The ring 20 has two complete turns and a little more of the wire 22 and each end of the wire terminates in a loop 24 and a tail 26. The tails 26 extend back towards each other. The tails 26 extend back around the periphery of the reinforcing ring and when the wire is stretched out for passivation and/or electropolishing the tails are slightly spaced away from it (see FIG. 5). Each of the tails 26 ends in an enlarged end 27.
  • FIG. 4 shows a reinforcing ring according to the embodiment shown in FIG. 2 stitched into a portion of graft material. The graft material 30 has a fenestration 32 and around the fenestration is a reinforcing ring 10 retained in place by blanket type stitching 36. In this embodiment the reinforcing ring 10 is of the type shown in FIG. 2 and the loops 14 overlap and two of the stitches of the stitching pass through the loops 14. These extra stitches 37 are provided into the loops 14 and through the graft material. The tails 16 are also retained within the stitches 36. It will be noted in particular that the stitch 36 a engages against the enlarged end or ball 17.
  • FIG. 5 shows a reinforcing ring according to the embodiments shown in FIGS. 1 to 3 stretched out for passivation and/or electropolishing. The wire 40 is stretched essentially by pulling upon the tails 42 at each end out so that no portion of the rings, loops or tails touch another. It will be particularly noted that when stretched out the tail 42 does not touch the wire 40 thereby ensuring good electropolishing all over the wire.
  • FIG. 6 shows a stent graft incorporating fenestrations and a reinforcing ring according to the present invention. A stent graft 50 comprises a tubular wall body portion 53. The tubular wall body portion is a biocompatible graft material such as Dacron, Thoralon, expanded PTFE material or a naturally occurring biomaterial, such as an extracellular matrix, such as small intestinal submucosa or other suitable material.
  • Gianturco style zig zag Z stents 55 are provided inside the graft material at each end and on the central tubular wall body portion Gianturco style zig zag Z stents 57 are provided on the outside of the graft material. There may be further Gianturco style zig zag Z stents than those illustrated depending upon the overall length of the stent graft 50. Other forms of stent may also be used.
  • In the tubular wall body portion 53 there are two substantially circular fenestrations or apertures 59 on the tubular wall of the stent graft. In this embodiment there are two fenestrations being one for each of the two renal arteries when this embodiment is deployed into the aorta. Other numbers of fenestrations may also be used where the placement of the stent graft involves the possibility of occluding other branch vessels such as the superior mesenteric artery and the celiac artery. The fenestrations 59 are substantially circular. Radiopaque markers 61 are provided at each end of the fenestration 59 to assist a physician to locate the fenestration 59 in respect to a side vessel extending from a main vessel. The radiopaque markers 61 may be gold or other convenient material.
  • A reinforcement ring 62 of the present invention is provided around the periphery of the fenestration 59 to give good dimensional stability to the fenestration 59. The reinforcing ring is manufactured from Nitinol wire. In an alternative arrangement the ring 62 may be formed from stainless steel or any other convenient material. Stitching 63 is provided to retain the ring 62 around the periphery of the fenestration 59.
  • Also in FIG. 6 there is shown a scalloped fenestration 65 which opens to the end 67 of the stent graft.
  • FIG. 7 shows an alternative embodiment of the invention. In this embodiment the reinforcing ring 70 has nearly two full turns of Nitinol wire 72 and each end of the wire terminates in a loop 74. Each of the loops extend out of the plane of the circular shape at approximately right angles thereto. The tails 76 of the loops extend around the periphery of the circular shape and each of the tails 76 ends in an enlarged end 78.
  • The reinforcement ring of this embodiment is useful as a reinforcing ring at the end of a tubular body of graft material such as an arm or leg of a stent graft where the ring is stitched around the end of the tubular body and the loops at right angles to the plane of the ring extend along the tubular body and can be stitched thereto.
  • FIG. 8 shows a leg extension stent graft incorporating a ring reinforcement of the embodiment of FIG. 7. In FIG. 8 the leg extension 80 has a tubular body 82 of a graft material and a reinforcement ring 70 at its proximal end 84.
  • The ring has loops 74 which extend out of the plane of the circular shape of the ring at approximately right angles and along the side of the tubular body. Stitching 86 fastens the ring to the tubular body and also some of the stitches pass through the loops 74 and over the tails 76.
  • Throughout this specification various indication have been made as to the scope of the invention but the invention is not limited to any one of these but may reside in more than one combined together. The example and embodiments are given for illustration only and not for limitation.

Claims (9)

1. A reinforcing ring for a fenestration of a stent graft, the reinforcing ring comprising a plurality of turns of a substantially inextensible resilient wire in a circular two dimensional planar shape and terminal ends at each end of the wire, the terminal ends each comprising a loop and a tail, the tail being folded back and extending around the circular shape.
2. A reinforcing ring as in claim 1 wherein the substantially inextensible resilient wire comprises a superelastic wire.
3. A reinforcing ring as in claim 1 wherein the wire comprises a nickel titanium alloy.
4. A reinforcing ring as in claim 1 wherein there are approximately two circular turns of the wire.
5. A reinforcing ring as in claim 1 wherein the terminal loops at each end of the wire overlap.
6. A reinforcing ring as in claim 1 wherein there are two complete circular turns of the wire and the loops extend further around the circular shape.
7. A reinforcing ring as in claim 1 wherein the terminal loops at each end of the wire extend out of the plane of the circular shape at approximately right angles thereto.
8. A reinforcing ring as in claim 1 wherein each of the tails of the terminal loops comprises an enlarged end.
9. A reinforcing ring for a fenestration of a stent graft, the reinforcing ring comprising a plurality of turns of a substantially inextensible resilient wire in a circular two dimensional planar shape and terminal ends at each end of the wire, the terminal ends each comprising a loop and a tail, the tail being folded back and extending around the circular shape, each of the tails of the terminal loops comprises an enlarged end and the wire comprising a passivated/electropolished surface.
US12/713,988 2009-06-10 2010-02-26 Reinforcing ring Abandoned US20100316830A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2009202301A AU2009202301B8 (en) 2009-06-10 2009-06-10 Reinforcing ring
AU2009202301 2009-06-10

Publications (1)

Publication Number Publication Date
US20100316830A1 true US20100316830A1 (en) 2010-12-16

Family

ID=40935101

Family Applications (2)

Application Number Title Priority Date Filing Date
US13/377,453 Active 2033-03-28 US9918823B2 (en) 2009-06-10 2010-02-26 Reinforcing ring
US12/713,988 Abandoned US20100316830A1 (en) 2009-06-10 2010-02-26 Reinforcing ring

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US13/377,453 Active 2033-03-28 US9918823B2 (en) 2009-06-10 2010-02-26 Reinforcing ring

Country Status (5)

Country Link
US (2) US9918823B2 (en)
EP (1) EP2440156B1 (en)
JP (1) JP5481645B2 (en)
AU (1) AU2009202301B8 (en)
WO (1) WO2010144162A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108261254A (en) * 2016-12-31 2018-07-10 先健科技(深圳)有限公司 Branch type overlay film frame
US11109965B2 (en) * 2020-02-06 2021-09-07 Laplace Interventional Inc. Transcatheter heart valve prosthesis assembled inside heart chambers or blood vessels
US11219540B2 (en) 2017-02-24 2022-01-11 Bolton Medical, Inc. Radially adjustable stent graft delivery system and method of use
US11278390B2 (en) 2017-02-24 2022-03-22 Bolton Medical, Inc. Stent graft with fenestration lock and methods of use
US11351025B2 (en) * 2017-02-24 2022-06-07 Bolton Medical, Inc. Vascular prosthesis with fenestration ring and methods of use
US11369466B2 (en) 2017-02-24 2022-06-28 Bolton Medical, Inc. Vascular prosthesis with moveable fenestration and method of use
US11376145B2 (en) 2017-10-31 2022-07-05 Bolton Medical, Inc. Distal torque component, delivery system and method of using same
US11399929B2 (en) * 2017-02-24 2022-08-02 Bolton Medical, Inc. Vascular prosthesis with crimped adapter and methods of use
US11413177B2 (en) 2017-02-24 2022-08-16 Bolton Medical, Inc. Stent graft delivery system with constricted sheath and method of use
US11491003B2 (en) 2017-02-24 2022-11-08 Bolton Medical, Inc. Constrainable stent graft, delivery system and methods of use
US11510777B1 (en) 2022-02-10 2022-11-29 Laplace Interventional Inc. Prosthetic heart valves
US11547584B2 (en) 2017-02-24 2023-01-10 Bolton Medical, Inc. Delivery system and method to radially constrict a stent graft
US11638643B1 (en) 2022-07-20 2023-05-02 Laplace Interventional Inc. Prosthetic heart valves
US11730584B2 (en) 2017-02-24 2023-08-22 Bolton Medical, Inc. System and method to radially constrict a stent graft
US11918460B2 (en) 2023-09-08 2024-03-05 Laplace Interventional Inc. Prosthetic heart valves

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010210022B1 (en) * 2010-08-05 2011-09-08 Cook Incorporated Stent graft having a marker and a reinforcing and marker ring
US8734504B2 (en) 2012-04-12 2014-05-27 Sanford Health Aortic arch double-barreled main body stent graft and methods for use
US10357353B2 (en) 2012-04-12 2019-07-23 Sanford Health Combination double-barreled and debranching stent grafts and methods for use
DK2836159T3 (en) * 2012-04-12 2018-08-27 Sanford Health DEBRANCHING STORKARSSTENTGRAFT
CN105030372B (en) * 2015-08-31 2017-03-01 东华大学 Partial gradient structural vessel support overlay film towards orthotopic fenestration and preparation method thereof
US10537419B2 (en) 2016-10-27 2020-01-21 Cook Medical Technologies Llc Prosthesis with branched portion

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4907336A (en) * 1987-03-13 1990-03-13 Cook Incorporated Method of making an endovascular stent and delivery system
US5554181A (en) * 1994-05-04 1996-09-10 Regents Of The University Of Minnesota Stent
US5653743A (en) * 1994-09-09 1997-08-05 Martin; Eric C. Hypogastric artery bifurcation graft and method of implantation
US6030414A (en) * 1997-11-13 2000-02-29 Taheri; Syde A. Variable stent and method for treatment of arterial disease
US6355052B1 (en) * 1996-02-09 2002-03-12 Pfm Produkte Fur Die Medizin Aktiengesellschaft Device for closure of body defect openings
US6395018B1 (en) * 1998-02-09 2002-05-28 Wilfrido R. Castaneda Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels
US6565581B1 (en) * 1996-09-16 2003-05-20 Origin Medsystems, Inc. Apparatus and method for performing an anastomosis
US20050102021A1 (en) * 2003-10-10 2005-05-12 Cook Incorporated Stretchable prosthesis fenestration
US20050131525A1 (en) * 2003-10-10 2005-06-16 William A. Cook Australia Pty. Ltd. Ring stent
US20070219621A1 (en) * 2006-02-13 2007-09-20 William A. Cook Australia Pty Ltd. Side branch stent graft construction
US7413573B2 (en) * 2003-10-10 2008-08-19 William A. Cook Australia Pty. Ltd. Fenestrated stent grafts
US7608086B2 (en) * 2003-09-30 2009-10-27 Ethicon Endo-Surgery, Inc. Anastomosis wire ring device
US7766861B2 (en) * 2002-12-02 2010-08-03 Gi Dynamics, Inc. Anti-obesity devices

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5713948A (en) * 1995-07-19 1998-02-03 Uflacker; Renan Adjustable and retrievable graft and graft delivery system for stent-graft system
US6582394B1 (en) * 2000-11-14 2003-06-24 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcated vessels
WO2004050161A1 (en) * 2002-12-02 2004-06-17 Wilson-Cook Medical Inc. Loop tip wire guide
EP1673039B1 (en) * 2003-10-10 2008-12-03 William A. Cook Australia Pty. Ltd. Stent graft fenestration
JP2008541873A (en) * 2005-05-23 2008-11-27 インセプト・リミテッド・ライアビリティ・カンパニー Apparatus and method for identifying small holes in blood vessels
WO2007084537A2 (en) * 2006-01-18 2007-07-26 William A. Cook Australia Pty. Ltd. Self expanding stent
WO2010030370A1 (en) 2008-09-12 2010-03-18 William A. Cook Australia Pty. Ltd. Radiopaque reinforcing member
US8506622B2 (en) * 2009-04-17 2013-08-13 Medtronic Vascular, Inc. Mobile external coupling for branch vessel connection
US8337546B2 (en) * 2010-04-29 2012-12-25 Medtronic Vascular, Inc. Mobile external coupling for branch vessel connection
US8551158B2 (en) * 2011-05-13 2013-10-08 Cook Medical Technologies Llc Steerable iliac branch device

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4907336A (en) * 1987-03-13 1990-03-13 Cook Incorporated Method of making an endovascular stent and delivery system
US5554181A (en) * 1994-05-04 1996-09-10 Regents Of The University Of Minnesota Stent
US5653743A (en) * 1994-09-09 1997-08-05 Martin; Eric C. Hypogastric artery bifurcation graft and method of implantation
US6355052B1 (en) * 1996-02-09 2002-03-12 Pfm Produkte Fur Die Medizin Aktiengesellschaft Device for closure of body defect openings
US6565581B1 (en) * 1996-09-16 2003-05-20 Origin Medsystems, Inc. Apparatus and method for performing an anastomosis
US6030414A (en) * 1997-11-13 2000-02-29 Taheri; Syde A. Variable stent and method for treatment of arterial disease
US6395018B1 (en) * 1998-02-09 2002-05-28 Wilfrido R. Castaneda Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels
US7766861B2 (en) * 2002-12-02 2010-08-03 Gi Dynamics, Inc. Anti-obesity devices
US7608086B2 (en) * 2003-09-30 2009-10-27 Ethicon Endo-Surgery, Inc. Anastomosis wire ring device
US20050102021A1 (en) * 2003-10-10 2005-05-12 Cook Incorporated Stretchable prosthesis fenestration
US20050131525A1 (en) * 2003-10-10 2005-06-16 William A. Cook Australia Pty. Ltd. Ring stent
US7413573B2 (en) * 2003-10-10 2008-08-19 William A. Cook Australia Pty. Ltd. Fenestrated stent grafts
US20070219621A1 (en) * 2006-02-13 2007-09-20 William A. Cook Australia Pty Ltd. Side branch stent graft construction

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108261254A (en) * 2016-12-31 2018-07-10 先健科技(深圳)有限公司 Branch type overlay film frame
US11547584B2 (en) 2017-02-24 2023-01-10 Bolton Medical, Inc. Delivery system and method to radially constrict a stent graft
US11491003B2 (en) 2017-02-24 2022-11-08 Bolton Medical, Inc. Constrainable stent graft, delivery system and methods of use
US11801129B2 (en) 2017-02-24 2023-10-31 Bolton Medical, Inc. Vascular prosthesis with fenestration ring and methods of use
US11779454B2 (en) 2017-02-24 2023-10-10 Bolton Medical, Inc. Vascular prosthesis with crimped adapter and methods of use
US11351025B2 (en) * 2017-02-24 2022-06-07 Bolton Medical, Inc. Vascular prosthesis with fenestration ring and methods of use
US11369466B2 (en) 2017-02-24 2022-06-28 Bolton Medical, Inc. Vascular prosthesis with moveable fenestration and method of use
US11219540B2 (en) 2017-02-24 2022-01-11 Bolton Medical, Inc. Radially adjustable stent graft delivery system and method of use
US11399929B2 (en) * 2017-02-24 2022-08-02 Bolton Medical, Inc. Vascular prosthesis with crimped adapter and methods of use
US11413177B2 (en) 2017-02-24 2022-08-16 Bolton Medical, Inc. Stent graft delivery system with constricted sheath and method of use
US11730584B2 (en) 2017-02-24 2023-08-22 Bolton Medical, Inc. System and method to radially constrict a stent graft
US11278390B2 (en) 2017-02-24 2022-03-22 Bolton Medical, Inc. Stent graft with fenestration lock and methods of use
US11376145B2 (en) 2017-10-31 2022-07-05 Bolton Medical, Inc. Distal torque component, delivery system and method of using same
US11701223B2 (en) 2020-02-06 2023-07-18 Laplace Interventional Inc. Transcatheter heart valve prosthesis assembled inside heart chambers or blood vessels
US11337801B2 (en) 2020-02-06 2022-05-24 Laplace Interventional Inc. Transcatheter heart valve prosthesis assembled inside heart chambers or blood vessels
US11109965B2 (en) * 2020-02-06 2021-09-07 Laplace Interventional Inc. Transcatheter heart valve prosthesis assembled inside heart chambers or blood vessels
US11672655B1 (en) 2022-02-10 2023-06-13 Laplace Interventional Inc. Prosthetic heart valves
US11510777B1 (en) 2022-02-10 2022-11-29 Laplace Interventional Inc. Prosthetic heart valves
US11712336B1 (en) 2022-07-20 2023-08-01 Laplace Interventional Inc. Prosthetic heart valves
US11638643B1 (en) 2022-07-20 2023-05-02 Laplace Interventional Inc. Prosthetic heart valves
US11759316B1 (en) 2022-07-20 2023-09-19 Laplace Interventional Inc. Prosthetic heart valves
US11806235B1 (en) 2022-07-20 2023-11-07 Laplace Interventional Inc. Prosthetic heart valves
US11918463B2 (en) 2023-04-17 2024-03-05 Laplace Interventional Inc. Prosthetic heart valves
US11918460B2 (en) 2023-09-08 2024-03-05 Laplace Interventional Inc. Prosthetic heart valves

Also Published As

Publication number Publication date
US9918823B2 (en) 2018-03-20
JP2012529341A (en) 2012-11-22
EP2440156A1 (en) 2012-04-18
EP2440156B1 (en) 2014-01-22
JP5481645B2 (en) 2014-04-23
AU2009202301B1 (en) 2009-07-30
AU2009202301B8 (en) 2009-12-03
WO2010144162A1 (en) 2010-12-16
US20120123523A1 (en) 2012-05-17

Similar Documents

Publication Publication Date Title
US9918823B2 (en) Reinforcing ring
EP2872679B1 (en) Methods for passivating metallic implantable medical devices including radiopaque markers
US6387123B1 (en) Stent with radiopaque core
US6652579B1 (en) Radiopaque stent
CA2711176C (en) Stent and method of making a stent
US7879367B2 (en) Metallic implant which is degradable in vivo
US20070055299A1 (en) Temporary stents and stent-grafts
WO2002005863A1 (en) Radiopaque stent composed of a binary alloy
CN104994892A (en) MRI visible medical device
US8747649B2 (en) Electrochemical formation of foil-shaped stent struts
CN214018001U (en) Support frame
EP2382340B1 (en) Method and solution for electropolishing stents made of high strength medical alloys
JP2002515785A (en) A group of endoluminal prostheses having certain characteristics and a method of manufacturing the same
JP2003260142A (en) Stent for intracranial blood vessel treatment, and production method
WO2018143115A1 (en) Bioabsorbable stent
JP6815606B2 (en) Bioabsorbable stent with marker and its manufacturing method

Legal Events

Date Code Title Description
AS Assignment

Owner name: WILLIAM A. COOK AUSTRALIA PTY. LTD., AN AUSTRALIAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HARTLEY, DAVID ERNEST;MILLS, EDWARD GRAHAM;SIGNING DATES FROM 20091203 TO 20091215;REEL/FRAME:024000/0281

Owner name: COOK INCORPORATED, A CORPORATION OF THE STATE OF I

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HARTLEY, DAVID ERNEST;MILLS, EDWARD GRAHAM;SIGNING DATES FROM 20091203 TO 20091215;REEL/FRAME:024000/0281

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION